Brainchip Short Discussion, page-632

I doubt retail will be selling shares to buy the SPP as firstly the subscription level is not guaranteed and tne max allowed value is 30000$ about 150000 shares. Thats about 100 holders if they took the full lot really not much available.

The shares for sale are actually at 20 cents cause you could put a bid in at 19.5 and I doubt you get hit cause the computers and high priority buyer jumps in front of your bid.

The 3 million raised is good for the company balance sheet. So I'm guessing there will be an uptake for that.

Likely the buyer of the 22 million set the floor and could buy the few real extra shares for sale at the 19.5 to 20 cent range or one that is not going to do the SPP. When those shares are absolutely dried up the price will crawl up as the 16 million shorts in the 22 to 20 cent range will need to cover. They likely slowly are doing it we should see in a few days.

I think the shorts thought more selling pressure with the LDA market sells could let them cover at a lower price but it's possible they got surprised with this arrangement.

It's also very rare to not have any warrants or options attached to a CR the discount was limited but as the reported the average sale price of the march raise was 27 cents so this suggests to me that the company has set a lower price value and looking at the offer of 19.3 would appear to be a steep discount from 27 so the sophisticated buyer may have viewed that as value to them.

So IMO i do see us crawl out of the teens finaly over the next 2 weeks and I guess we wait for mor confirmation on any IP deals.

The Airbus news is actually pretty big if you read it and understand that Akida did win the engagement with Airbus. This firstly means Airbus choose Akida over who ever else had chip technology on offer. Now they are doing a proposal for an end product to a customer. This is basicly an engagement for a $$ contract down the road if its a win then we will see $$ IMO.

So all is really not lost yeah takes time but you can see how complicated the pathway to commercial success it is. Im sure BRN had to first prove that their technology was compatible with what ever else was on offer and its integratable then you need to win with Airbus and then a proposal for an end user.

This tells me that progress is moving in the right direction. Sean weather you dislike him or not did build up the ecosystem and now you can see the results of it.

I truly believe the past leadership was somewhat unknowledgable about the pathway to comercial revenue what we heard in 2020 2021 was over optimism. What they need to do was build the system get wins and make money.

The ne additions to the science board I believe is more inline with the direction the company is heading which is good. Again this is likely a result of change. If there was any work accomplished within the medical field it appears Tata took it on.

I think when one will look back in the next few months you will see maybe this was all good. Maybe the SPP offering was a bit of a thanks to the long term holders that have waited maybe not. I do not think that extra 3 million AUD when they now have 43 million where critical in the raise as they likely do not know the response of who is happy who is not.

Even penetrating the market with standard technology is a minimum of 2 years. Contracts with old supplier and partners need to be managed. If that partner got Info on you are leaving for a new technology do you think that would affect the current relationship yeah it would definitely put you on a low priority hence much silence.

IMO
Have a great weekend folks.